ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

SAIC-Frederick Makes Awards To Proteomics Research Teams.

January 14, 2005

Study Shows Early Treatment Of Asymptomatic Myeloma Can Improve Survival

August 30, 2013

R. Lee Clark, 87, M.D. Anderson Mastermind, dies

May 13, 1994

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

McDonald’s Charity Commits $5 Million To Pediatric Research

May 17, 1991

Program Announcement In Preventative Oncology

May 21, 1982